NanoViricides Inc. (NNVC) Financial Statements (2025 and earlier)

Company Profile

Business Address 1 CONTROLS DRIVE
SHELTON, CT 06484
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2024
MRQ
6/30/2024
12/31/2023
MRQ
6/30/2023
6/30/2022
6/30/2021
6/30/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,797,7785,245,3748,149,80814,066,35920,516,67713,708,594
Cash and cash equivalents4,797,7785,245,3748,149,80814,066,35920,516,67713,708,594
Prepaid expense172,74272,442295,486350,021307,102277,063
Total current assets:4,970,5205,317,8168,445,29414,416,38020,823,77913,985,657
Noncurrent Assets
Property, plant and equipment7,512,4637,746,0928,106,6478,694,1949,084,9019,544,431
Intangible assets, net (including goodwill)325,308329,443333,578341,848350,118358,388
Intangible assets, net (excluding goodwill)325,308329,443333,578341,848350,118358,388
Other undisclosed noncurrent assets14,5628,85914,36142,4403,51525,863
Total noncurrent assets:7,852,3338,084,3948,454,5869,078,4829,438,5349,928,682
TOTAL ASSETS:12,822,85313,402,21016,899,88023,494,86230,262,31323,914,339
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities262,467180,372143,760142,328224,301449,967
Employee-related liabilities38,676  
Accounts payable    57,960200,016380,727
Accrued liabilities262,467180,372143,76045,69224,28569,240
Due to related parties 214,39731,539561,580
Other undisclosed current liabilities1,096,309770,702390,49056,11295,3061,144,830
Total current liabilities:1,358,776951,074534,250412,837351,1462,156,377
Noncurrent Liabilities
Long-term debt and lease obligation   1,500,000   
Long-term debt, excluding current maturities   1,500,000   
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:  1,500,000   
Total liabilities:1,358,776951,0742,034,250412,837351,1462,156,377
Equity
Equity, attributable to parent, including:11,464,07712,451,13614,865,63023,082,02529,911,16721,757,962
Common stock13111711611,59211,5159,083
Additional paid in capital150,838,832147,615,441145,946,258145,562,124144,284,593127,311,634
Accumulated deficit(139,374,895)(135,164,431)(131,080,749)(122,492,176)(114,385,313)(105,563,124)
Other undisclosed equity, attributable to parent995485372369
Other undisclosed equity      
Total equity:11,464,07712,451,13614,865,63023,082,02529,911,16721,757,962
TOTAL LIABILITIES AND EQUITY:12,822,85313,402,21016,899,88023,494,86230,262,31323,914,339

Income Statement (P&L) (USD)

9/30/2024
TTM
6/30/2024
12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating expenses(8,516,111)(9,703,461)(8,943,468)(8,113,599)(8,744,106)(7,996,459)
Operating loss:(8,516,111)(9,703,461)(8,943,468)(8,113,599)(8,744,106)(7,996,459)
Nonoperating income (expense)221,965346,981354,8956,736(78,083)(5,450,079)
Other nonoperating income271,773396,789355,83311,8599,34817,079
Interest and debt expense(49,808)(49,808)(938)(5,123)(85,405)(93,670)
Loss from continuing operations before equity method investments, income taxes:(8,343,954)(9,406,288)(8,589,511)(8,111,986)(8,907,594)(13,540,208)
Other undisclosed income from continuing operations before income taxes  35,555 5,12385,40593,670
Loss from continuing operations before income taxes:(8,343,954)(9,370,733)(8,589,511)(8,106,863)(8,822,189)(13,446,538)
Income tax expense    (1,258)  
Loss from continuing operations:(8,343,954)(9,370,733)(8,589,511)(8,108,121)(8,822,189)(13,446,538)
Loss before gain (loss) on sale of properties:(8,108,121)(8,822,189)(13,446,538)
Other undisclosed net income 49,8089389381,258  
Net loss:(8,294,146)(9,369,795)(8,588,573)(8,106,863)(8,822,189)(13,446,538)
Other undisclosed net income attributable to parent 13,315    
Net loss available to common stockholders, diluted:(8,294,146)(9,356,480)(8,588,573)(8,106,863)(8,822,189)(13,446,538)

Comprehensive Income (USD)

9/30/2024
TTM
6/30/2024
12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Net loss:(8,294,146)(9,369,795)(8,588,573)(8,106,863)(8,822,189)(13,446,538)
Comprehensive loss, net of tax, attributable to parent:(8,294,146)(9,369,795)(8,588,573)(8,106,863)(8,822,189)(13,446,538)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: